MENA: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in MENA

The MENA's medicaments containing insulin market reduced markedly to $X in 2021, dropping by -35.7% against the previous year. In general, consumption faced a drastic downturn. The level of consumption peaked at $X in 2012; however, from 2013 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in MENA

In value terms, medicaments containing insulin production dropped significantly to $X in 2021 estimated in export price. Over the period under review, production, however, saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2020 with an increase of 65%. The level of production peaked at $X in 2018; however, from 2019 to 2021, production remained at a lower figure.

Medicaments Containing Insulin Exports

Exports in MENA

In 2021, exports of medicaments containing insulin but not antibiotics in MENA declined remarkably to X tons, shrinking by -31.1% on 2020. In general, exports saw a noticeable reduction. The pace of growth appeared the most rapid in 2020 when exports increased by 109%. The volume of export peaked at X tons in 2012; however, from 2013 to 2021, the exports remained at a lower figure.

In value terms, medicaments containing insulin exports shrank remarkably to $X in 2021. Overall, exports recorded a abrupt shrinkage. The growth pace was the most rapid in 2020 when exports increased by 101% against the previous year. The level of export peaked at $X in 2012; however, from 2013 to 2021, the exports remained at a lower figure.

Exports by Country

The United Arab Emirates (X tons) and Jordan (X tons) prevails in exports structure, together creating 92% of total exports. It was distantly followed by Israel (X kg), generating a 5.4% share of total exports. Egypt (X kg) took a minor share of total exports.

From 2012 to 2021, the biggest increases were recorded for Israel (with a CAGR of +39.9%), while shipments for the other leaders experienced mixed trends in the exports figures.

In value terms, the United Arab Emirates ($X) remains the largest medicaments containing insulin supplier in MENA, comprising 61% of total exports. The second position in the ranking was taken by Jordan ($X), with a 26% share of total exports. It was followed by Egypt, with a 6.9% share.

In the United Arab Emirates, medicaments containing insulin exports decreased by an average annual rate of -19.0% over the period from 2012-2021. In the other countries, the average annual rates were as follows: Jordan (-5.6% per year) and Egypt (-11.7% per year).

Export Prices by Country

The export price in MENA stood at $X per ton in 2021, picking up by 17% against the previous year. Over the period under review, the export price, however, continues to indicate a abrupt downturn. The pace of growth appeared the most rapid in 2013 when the export price increased by 21% against the previous year. As a result, the export price attained the peak level of $X per ton. From 2014 to 2021, the export prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Egypt ($X per ton), while Jordan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Egypt (+4.3%), while the other leaders experienced a decline in the export price figures.

Medicaments Containing Insulin Imports

Imports in MENA

In 2021, supplies from abroad of medicaments containing insulin but not antibiotics decreased by -40.9% to X tons, falling for the second consecutive year after two years of growth. Overall, imports continue to indicate a abrupt contraction. The most prominent rate of growth was recorded in 2016 when imports increased by 94%. As a result, imports attained the peak of X tons. From 2017 to 2021, the growth of imports failed to regain momentum.

In value terms, medicaments containing insulin imports fell significantly to $X in 2021. In general, imports recorded a abrupt curtailment. The growth pace was the most rapid in 2018 with an increase of 130%. Over the period under review, imports attained the peak figure at $X in 2012; however, from 2013 to 2021, imports failed to regain momentum.

Imports by Country

In 2021, Kuwait (X tons) represented the main importer of medicaments containing insulin but not antibiotics, achieving 66% of total imports. Tunisia (X tons) took a 20% share (based on physical terms) of total imports, which put it in second place, followed by Iran (8.3%). The following importers - Qatar (X tons) and Iraq (X tons) - together made up 5.6% of total imports.

Kuwait was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics imports, with a CAGR of +8.8% from 2012 to 2021. At the same time, Iran (+4.0%) displayed positive paces of growth. By contrast, Qatar (-13.4%), Iraq (-20.2%) and Tunisia (-22.6%) illustrated a downward trend over the same period. While the share of Kuwait (+55 p.p.) and Iran (+6.2 p.p.) increased significantly in terms of the total imports from 2012-2021, the share of Iraq (-3.8 p.p.) and Tunisia (-50.3 p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest medicaments containing insulin importing markets in MENA were Kuwait ($X), Tunisia ($X) and Iran ($X), with a combined 61% share of total imports.

Among the main importing countries, Kuwait, with a CAGR of +2.9%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced a decline in the imports figures.

Import Prices by Country

The import price in MENA stood at $X per ton in 2021, picking up by 21% against the previous year. Overall, the import price, however, recorded a abrupt descent. The pace of growth appeared the most rapid in 2017 an increase of 130% against the previous year. The level of import peaked at $X per ton in 2012; however, from 2013 to 2021, import prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Iran ($X per ton), while Qatar ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Iraq (+4.3%), while the other leaders experienced a decline in the import price figures.

Source: IndexBox Market Intelligence Platform

Frequently Asked Questions (FAQ) :